EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Trans Oral Robotic Surgery for HPV ‐Negative Oropharyngeal Squamous Cell Carcinoma: Follow‐Up on Oncological and Functional Outcomes

Khalid Azalmad, Karma Lambercy, Avinash Beharry, Nathalie Piazzon, Marie Barbesier, Margaux Dalla-Vale, Manuela Moraru, Sabina Berezowska, Christian Simon iD

Head & Neck · 2025

DOI: 10.1002/hed.27958 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head & Neck, 2025. Verfasst von Khalid Azalmad und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, CHUV, University of Lausanne, Lausanne, Switzerland. Hauptthemen laut MEDLINE: Oropharyngeal Neoplasms, Robotic Surgical Procedures, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The efficacy of transoral robotic surgery (TORS) for HPV‐negative oropharyngeal cancers (OPSCC) is less explored, especially regarding long‐term outcomes and prognostic factors.

Methods

We conducted a retrospective monocentric study on 37 patients with HPV‐negative OPSCC treated with TORS with a median follow‐up of 3 years, assessing survival outcomes using Kaplan‐Meyer statistics and swallowing function via the functional outcome swallowing scale (FOSS). Histopathological parameters were collected either from medical records or histology slides were re‐evaluated.

Results

Patients demonstrated high disease‐specific survival (DSS) but lower overall survival (OS), with a cohort characterized by high comorbidity rates. Vascular invasion was a significant adverse factor for relapse‐free survival (RFS) and OS, while lymphatic invasion was not. Most patients demonstrated significant preservation of swallowing function.

Conclusions

TORS for HPV‐negative OPSCC demonstrates high DSS and preserved swallowing function. Vascular invasion is a key prognostic factor for survival outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oropharyngeal NeoplasmsRobotic Surgical ProceduresCarcinoma, Squamous CellHumansMaleFemaleRetrospective StudiesMiddle AgedAgedFollow-Up StudiesAdultTreatment OutcomeDeglutitionDisease-Free SurvivalPrognosisNeoplasm InvasivenessAged, 80 and overKaplan-Meier Estimate

Stichwörter der Autor:innen

HPV‐negativehead and neck cancer—squamous cell carcinomaoropharynx cancertransoral robotic surgery

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, CHUV, University of Lausanne, Lausanne, Switzerland.
  • Department of Laboratory Medicine and Pathology, Institute of Pathology, CHUV, University of Lausanne, Lausanne, Switzerland.

ORCID-Profile: Christian Simon

Zitieren

APA

Azalmad, K., Lambercy, K., Beharry, A., Piazzon, N., Barbesier, M., Dalla-Vale, M., Moraru, M., Berezowska, S., & Simon, C. (2025). Trans Oral Robotic Surgery for HPV ‐Negative Oropharyngeal Squamous Cell Carcinoma: Follow‐Up on Oncological and Functional Outcomes. Head & Neck. https://doi.org/10.1002/hed.27958

Vancouver

Azalmad K, Lambercy K, Beharry A, Piazzon N, Barbesier M, Dalla-Vale M, et al. Trans Oral Robotic Surgery for HPV ‐Negative Oropharyngeal Squamous Cell Carcinoma: Follow‐Up on Oncological and Functional Outcomes. Head & Neck. 2025. doi:10.1002/hed.27958

BibTeX
@article{Azalmad2025,
  author = {Azalmad, Khalid and Lambercy, Karma and Beharry, Avinash and Piazzon, Nathalie and Barbesier, Marie and Dalla-Vale, Margaux and Moraru, Manuela and Berezowska, Sabina and Simon, Christian},
  title = {Trans Oral Robotic Surgery for HPV ‐Negative Oropharyngeal Squamous Cell Carcinoma: Follow‐Up on Oncological and Functional Outcomes},
  journal = {Head & Neck},
  year = {2025},
  doi = {10.1002/hed.27958}
}
Kostenlos starten →